Tag: NWBO

Blue Horseshoe Stocks: IDXG Update & More

Interpace Diagnostics Group, Inc. IDXG

We tracked IDXG last week over a couple of stellar sessions that led to a swing of more than 400%, cautioning that a dip-and-rip could be in the cards after seeing such a volatile move to the upside.

That’s exactly what we’ve seen in the past couple of days, as IDXG came down to find support at the .865 level, and in the ensuing three sessions it’s been steadily registering higher highs and higher lows, getting back to 1.25 yesterday (+45%).

We’ll continue to follow this story, which kicked off with the revelation that Aetna would cover Interpace’s ThyraMir™ test for its 46 million insured members. (>>View PR)

Experience Art & Design, Inc. EXAD

We had EXAD tagged in yesterday’s premarket report and this subpenny play produced a moderate run to kick off the session, even as the larger markets were struggling with the Fed rate hike announcement.

From an early low of .0023, the stock took just the first hour of trading to find its way up to a high of .0038, for a 65% pop. IDXG hung around that level until around lunchtime, and it did come back down to its daily low toward the close, so we’ll be looking for the possibility of a rebound.

Catalyst Biosciences, Inc. CBIO

We’re also interested in following the activity of CBIO today, which is gapping up in the premarket to the tune of more than 100% and looks like it could be lining up to have a big day. We’ll want to make sure it holds above its 50DMA (.80) on any pullbacks, but if it can breach past its 200DMA of 1.31, things could get very interesting.

News broke yesterday via an 8-K filing that CBIO had entered into a definitive agreement with Wyeth LLC, (wholly-owned subsidiary of Pfizer Inc.) to transfer exclusive rights to research, develop, manufacture and commercialize Factor VIIa variants, CB 813a and CB 813d, as well as transferring the investigational NDA to CBIO as well. (>>View Filing)


Fresh Options Idea:  Transocean, Inc. RIG $15 and $14.50 Puts

Extended Watchlist:
VCEL, NWBO, BCLI, BPMX, DLOV, PPMT

Blue Horseshoe Stocks: NWBO Review, Options & More

Northwest Biotherapeutics, Inc. NWBO

We’ve been mentioning NWBO this week beginning on Monday, and yesterday, despite already having seen some solid gains from the stock, we were met with a second consecutive solid intraday performance.

NWBO traded in a daily range from .551 to .76, which marked a surge to the upside of 38% and from our observed low subsequent to its appearance in our morning report on Monday (.5018), yesterday’s high represented a two-day swing of 51%

We’ll continue to track the progress here, and will be anxious to see if the stock can maintain it’s multi-day runner status.

More Bottom-Watchers

Yesterday we submitted a bottom watchlist consisting of three oversold stocks that we’re going to want to keep on our radars for the possibility of an eventual rebound (MGT, AIII, NVAX). This morning, we’d like to add a couple more to that list for us to monitor in sessions ahead.

Each of the following stocks appears to be egregiously oversold, and both have just registered new 52-week lows; two key components we look for when searching for potential recovery plays.

Gordman’s Stores, Inc. GMAN

Towerstream Corp. TWER

Fresh Options Ideas

We also want to delve back into the realm of options trading this morning, with a couple of ideas based on post-market earnings releases yesterday.

As our regular readers are well aware, we’ve used post-earnings options calls to find MAJOR short to intermediate-term success on countless occasions in the past, and these are just the types of plays for which we’re constantly scanning the landscape.

Our new targets are the following:

FDX Weekly $165-170 Calls

ADBE 10/21 $100-110 Calls

Extended Watchlist:
EBIO, GLRI, USLV, SFOR, LOGX, ADMS

Blue Horseshoe Stocks: APTY Recap & More

APT Systems, Inc. APTY

We reasserted our interest in APTY in yesterday’s morning report, after initially mentioning the stock on Friday prior to its respectable run of 38% that day from .0032 to .0044.

We were right to do so, as the stock opened up the new trading week with a bang. Maintaining support on a slight early morning dip at Friday’s swing high of .0044, the stock spent the remainder of the session on a steady uptrend.

Ultimately we witnessed a surge to a new high of .0069, which marked an intraday surge of 57%, and from our observed low of .0032 on Friday, it represents a two-day overall upswing of 116%

We’ll continue to have an eye peeled here, and APTY can sustain our interest by maintaining support at or above .0056 on any pullbacks.

Northwest Biotherapeutics, Inc. NWBO

We also want to make a quick note of NWBO, which we tagged in yesterday’s report as well, and will want to keep it on our radars moving forward for signs of further upward movement.

The move we observed was relatively modest, an intraday jump of 28% from .5018-.64, but more importantly, the stock carried over the momentum from the previous session, and we’re going to be on the lookout for that to continue. We’ll have a spot reserved on our tracker for NWBO as long as it continues to register these higher highs and higher lows.

Bottom-Watchlist

In lieu of our typical ‘Extended Watchlist’, today we’re just going to go with a bottom-watchlist. The following plays are trading near recent relative lows, and qualify for oversold status.

MGT Capital Investments, Inc. MGT – We’ll have MGT on a passive watch, as it seems like it could have a little farther to fall before making a rebound. We’ll look for it to ultimately find support and make a reversal at or above the current 200DMA of 1.58.

The company has just been denied the issuance of 43.8M shares by the NYSE regulatory office that are needed to close MGT’s acquisition of D-Vasive. The eventual rebound may possibly coincide with the resolution of this temporary roadblock.  (>>View PR)
______

ACRE Realty LP (AIII) – As a result of trepidation over interest rate hike speculation, Real Estate Investment Trusts like AIII have been taking a pounding. As the aforementioned play, there could still be some room to the downside, so we’ll have to keep a careful watch for a bottom over the next few sessions.
______

NovaVax, Inc. NVAX –  We also want to provide an update on another bottom-play we brought to the table yesterday morning. We noticed a mega gap-down on the chart as the stock fell from the $8-range to the $1-range on Friday, and to start out the week, NVAX did manage to record higher highs and higher lows, although there has been no major PPS increase just yet. We’ll continue to monitor for a more significant rebound off of its recent bottom.